CCELCryo-Cell International, Inc.

$25M

Q3 2017 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$7M+8.9% YoY

Gross Profit

$5M71.3% margin

Operating Income

$1M21.1% margin

Net Income

$652,0199.5% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+10.6%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$1M

Stock-Based Comp.

$238,154

Balance Sheet

Total Assets

$21M

Total Liabilities

$35M

Stockholders' Equity

-$13M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+8.9%
Gross Profit	$5M	$5M	+2.9%
Operating Income	$1M	-$1M	+236.7%
Net Income	$652,019	-$3M	+124.7%

Revenue Segments

Umbilical Cord Blood And Cord Tissue Stem Cell Service

$7M98%

Prepacyte-CB

$115,3762%

Geographic Segments

INDIA

$492,208100%

CCEL Q3 2017 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena